---
title: "KRBPQ.US (KRBPQ.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KRBPQ.US/news.md"
symbol: "KRBPQ.US"
name: "KRBPQ.US"
parent: "https://longbridge.com/en/quote/KRBPQ.US.md"
datetime: "2026-03-04T17:16:29.550Z"
locales:
  - [en](https://longbridge.com/en/quote/KRBPQ.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KRBPQ.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KRBPQ.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/KRBPQ.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/KRBPQ.US/news.md)


# KRBPQ.US (KRBPQ.US) — Related News

### [Kiromic BioPharma ($KRBPQ) Is Paying a $2.3M Settlement to Investors — Here’s How to Get Your Share](https://longbridge.com/en/news/260086780.md)
*2025-10-06T18:24:24.000Z*
> Kiromic BioPharma ($KRBPQ) has agreed to pay a $2.3 million settlement to investors over its 2021 IPO. Eligible claimant

### [Kiromic Biopharma, Inc. SEC 10-K Report](https://longbridge.com/en/news/228396962.md)
*2025-02-14T21:18:01.000Z*
> Kiromic Biopharma, Inc. has released its annual 10-K report detailing its financial performance and business operations.

### [Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation | KRBP Stock News](https://longbridge.com/en/news/221309406.md)
*2024-12-03T16:02:00.000Z*
> Kiromic BioPharma, Inc. has settled an SEC investigation regarding the non-disclosure of clinical holds on its IND appli

### [Kiromic BioPharma's Deltacel-01 Phase 1 Trial Shows Early Efficacy At Sixth Week](https://longbridge.com/en/news/205101779.md)
*2024-05-29T13:14:51.000Z*
> Kiromic BioPharma's Deltacel-01 Phase 1 trial shows favorable safety, tolerability, and early efficacy in patients with